961.14(7)(L)26. 26. Alpha-methylamino-butyrophenone, commonly known as buphedrone or MABP.
961.14(7)(L)27. 27. 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone, commonly known as MDPBP.
961.14(7)(L)28. 28. 4-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.
961.14(7)(L)29. 29. N,N-dimethyl-3,4-methylenedioxycathinone.
961.14(7)(L)30. 30. N,N-diethyl-3,4-methylenedioxycathinone.
961.14(7)(L)31. 31. Alpha-methylamino-valerophenone, commonly known as pentedrone.
961.14(7)(L)32. 32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP.
961.14(7)(L)33. 33. Alpha-pyrrolidinobutiophenone, commonly known as a-PBP.
961.14(7)(L)34. 34. N-Ethylpentylone, commonly known as ephylone.
961.14(7)(L)35. 35. N-Ethylhexedrone.
961.14(7)(L)36. 36. Alpha-pyrrolidinohexanophenone, commonly known as a-PHP.
961.14(7)(L)37. 37. 4-methyl-alpha-ethylainopentiophenone, commonly known as 4-MEAP.
961.14(7)(L)38. 38. 4'-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.
961.14(7)(L)39. 39. Alpha-pyrrolidinoheptaphenone, commonly known as PV8.
961.14(7)(L)40. 40. 4'-chloro-alpha-pyrrolidinovalerophenone, commonly known as 4-chloro-a-PVP.
961.14(7)(mk) (mk) Mitragynine.
961.14(7)(mL) (mL) 7-hydroxymitragynine.
961.14(7)(mm) (mm) 5,6-methylenedioxy-2-aminoindane, commonly known as MDAI.
961.14(7)(mn) (mn) Benzothiophenylcyclohexylpiperidine, commonly known as BTCP.
961.14(7)(p) (p) 4-methylthioamphetamine, commonly known as “4-MTA."
961.14(7)(q) (q) N- benzylpiperazine, commonly known as “BZP."
961.14(7)(r) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine.
961.14(7)(s) (s) N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate, commonly known as Mesocarb.
961.14(7)(t) (t) N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly known as Methiopropamine.
961.14 History History: 1971 c. 219; 1981 c. 206; 1989 a. 121; 1993 a. 98, 118; 1995 a. 225; 1995 a. 448 ss. 157 to 165; Stats. 1995 s. 961.14; 1997 a. 220; 1999 a. 21; 2001 a. 16; 2005 a. 52; 2011 a. 31; 2013 a. 267, 351; 2017 a. 4, 60, 100; 2017 a. 364 s. 49; 2017 a. 365 s. 111; 2019 a. 68; 2021 a. 240 s. 30; ss. CSB 2.15, 2.16, 2.17, 2.18, 2.19, 2.20, 2.21, 2.22, 2.31, 2.32, 2.33, 2.34, 2.41, 2.42, 2.45, 2.46, 2.47, 2.49, 2.50, 2.51, 2.52, 2.53, 2.55, 2.56, 2.57, 2.59, 2.60, 2.61, 2.62, 2.63, 2.64, 2.66, 2.68, 2.70, 2.72, 2.75, 2.78, 2.81, 2.83, 2.90, 2.91, 2.94, 2.96, 2.97, 2.99, 2.001, 2.003, Wis. adm. code.
961.14 Note NOTE: See 1979-80 stats. and 1993-94 stats. for notes on actions by the Controlled Substances Board under s. 161.11 (1), 1993 stats.
961.14 Annotation A chemical test need not be specifically for marijuana in order to be probative beyond a reasonable doubt. State v. Wind, 60 Wis. 2d 267, 208 N.W.2d 357 (1973).
961.14 AnnotationTHC is properly classified as Schedule I substance. State v. Olson, 127 Wis. 2d 412, 380 N.W.2d 375 (Ct. App. 1985).
961.14 Annotation Stems and branches supporting marijuana leaves or buds are not “mature stalks" under s. 961.01 (14). State v. Martinez, 210 Wis. 2d 396, 563 N.W.2d 922 (Ct. App. 1997), 96-1899.
961.15 961.15 Schedule II tests.
961.15(1m)(1m)The controlled substances board shall add a substance to schedule II upon finding that:
961.15(1m)(a) (a) The substance has high potential for abuse;
961.15(1m)(b) (b) The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and
961.15(1m)(c) (c) The abuse of the substance may lead to severe psychological or physical dependence.
961.15(2m) (2m)The controlled substances board may add a substance to schedule II without making the findings required under sub. (1m) if the substance is controlled under schedule II of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.15 History History: 1971 c. 219; 1995 a. 448 ss. 166, 167, 472; Stats. 1995 s. 961.15.
961.16 961.16 Schedule II. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule II:
961.16(2) (2) Substances of plant origin. Any material, compound, mixture or preparation which contains any quantity of any of the following substances in any form, including a substance contained in a plant, obtained from a plant, chemically synthesized or obtained by a combination of extraction from a plant and chemical synthesis:
961.16(2)(a) (a) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nalbuphine, butorphanol, naldemedine, nalmefene, naloxegol, naloxone, 6-beta-naltrexol, and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
961.16(2)(a)1. 1. Opium, including raw opium, opium extracts, opium fluid extracts, powdered opium, granulated opium and tincture of opium.
961.16(2)(a)2. 2. Opium poppy and poppy straw.
961.16(2)(a)3. 3. Concentrate of poppy straw, which is the crude extract of poppy straw in either liquid, solid or powder form containing the phenanthrene alkaloids of the opium poppy.
961.16(2)(a)4. 4. Codeine.
961.16(2)(a)4m. 4m. Dihydrocodeine.
961.16(2)(a)4r. 4r. Dihydroetorphine.
961.16(2)(a)5. 5. Ethylmorphine.
961.16(2)(a)6. 6. Etorphine hydrochloride.
961.16(2)(a)7. 7. Hydrocodone, also known as dihydrocodeinone.
961.16(2)(a)8. 8. Hydromorphone, also known as dihydromorphinone.
961.16(2)(a)9. 9. Metopon.
961.16(2)(a)10. 10. Morphine.
961.16(2)(a)10m. 10m. Noroxymorphone.
961.16(2)(a)11. 11. Oxycodone.
961.16(2)(a)12. 12. Oxymorphone.
961.16(2)(a)13. 13. Thebaine.
961.16(2)(b) (b) Coca leaves and any salt, compound, derivative, or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. [123I]Ioflupane and [18 F]FP-CIT are excluded from this paragraph. The following substances and any of their salts, esters, isomers, and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
961.16(2)(b)1. 1. Cocaine.
961.16(2)(b)2. 2. Ecgonine.
961.16(3) (3) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.16(3)(a) (a) Alfentanil;
961.16(3)(am) (am) Alphaprodine;
961.16(3)(b) (b) Anileridine;
961.16(3)(c) (c) Bezitramide;
961.16(3)(cm) (cm) Carfentanil;
961.16(3)(e) (e) Diphenoxylate;
961.16(3)(f) (f) Fentanyl;
961.16(3)(g) (g) Isomethadone;
961.16(3)(gm) (gm) Levo-alphacetylmethadol (LAAM);
961.16(3)(h) (h) Levomethorphan;
961.16(3)(j) (j) Levorphanol;
961.16(3)(k) (k) Meperidine, also known as pethidine;
961.16(3)(m) (m) Meperidine — Intermediate — A, 4-cyano-1-methyl-4- phenylpiperidine;
961.16(3)(n) (n) Meperidine — Intermediate — B, ethyl-4-phenylpiperidine- 4-carboxylate;
961.16(3)(p) (p) Meperidine — Intermediate — C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
961.16(3)(q) (q) Metazocine;
961.16(3)(r) (r) Methadone;
961.16(3)(s) (s) Methadone — Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;
961.16(3)(t) (t) Moramide — Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid;
961.16(3)(ta) (ta) Oliceridine;
961.16(3)(tb) (tb) Oripavine;
961.16(3)(u) (u) Phenazocine;
961.16(3)(v) (v) Piminodine;
961.16(3)(w) (w) Racemethorphan;
961.16(3)(x) (x) Racemorphan;
961.16(3)(xm) (xm) Remifentanil;
961.16(3)(y) (y) Sufentanil;
961.16(3)(zt) (zt) Tapentadol;
961.16(3)(zx) (zx) Thiafentanil.
961.16(5) (5) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
2021-22 Wisconsin Statutes updated through 2023 Wis. Act 39 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on November 29, 2023. Published and certified under s. 35.18. Changes effective after November 29, 2023, are designated by NOTES. (Published 11-29-23)